跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,830 条关于
“CR Bard”
全部
2,830
临床试验
1,739
药物
246
机构
66
资讯
779
上个月
BD Completes Enrollment in Landmark PREVENT Trial Evaluating Phasix Mesh for Incisional Hernia Prevention
去年
Xeltis Completes Enrollment in EU Pivotal Trial for aXess Vascular Access Conduit
去年
ASCT After First Complete Remission May Improve Outcomes in AML
10个月前
Crescent Biopharma's CR-001 Bispecific Antibody Shows Cooperative Pharmacology in Preclinical Studies
去年
Bendamustine-Obinutuzumab Improves Complete Response in Mantle Cell Lymphoma
去年
Leyden Labs Advances Novel Broad-Spectrum Nasal Antibody CR-9114 Against Multiple Influenza Strains
10个月前
Crescent Biopharma Advances PD-1 x VEGF Bispecific Antibody CR-001 Toward Phase 1 Trial
去年
FDA Approves Revumenib for Relapsed/Refractory Acute Leukemia with KMT2A Translocation
去年
Venetoclax-Based Induction Therapy Shows High Remission Rates in Pediatric AML
去年
FDA Approves Revumenib for Relapsed/Refractory Acute Leukemia with KMT2A Translocation
第 1 页,共 78 页
上一页
下一页